top of page
​Leveraging the Stabl framework for anti-PD1 response biomarker discovery in head and neck squamous cell carcinoma using the TruTumor ex vivo platform
This poster highlights Stabl’s ability to enable robust biomarker discovery from small-n, high-dimensional datasets and uncover complex response patterns.
Enter your details to see the full poster now
bottom of page